By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
New researcher findings on hepatitis C were among the scientific developments discussed at the 2019 Conference on Retroviruses and Opportunistic Infections.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
USPSTF reaffirms recommendation on screening for hepatitis B infection in pregnant women at their first prenatal visit to prevent infection in newborns.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
New Funding Opportunity Announcement from NIH’s NIAID will support research on a hepatitis B cure for HIV/HBV coinfection and HBV monoinfection.
By: Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Request for information seeks input on the development of study design, outcomes, and necessary partnerships for this integrated addiction research project.
By: Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
OHAIDP & OWH funded the National Academies to explore how the opioid epidemic is changing the epidemiology of HIV, hepatitis, & other infectious diseases.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
New HHS/AHRQ analysis examines trends in the number and rate of hepatitis C-related inpatient hospital stays, underscoring increasing healthcare burden.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Perinatal transmission is the leading cause of childhood HCV infection. According to CDC, maternal HCV infections nearly doubled from 2009 to 2014, and the number of infants born to women who are infected with HCV also increased.
By: Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Over 12,000 public health professionals attended APHA's 2017 Annual Meeting. The meeting highlighted the importance of viral hepatitis to the public’s health.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Clinician Consultation Center provides hepatitis C patient management consultation services on HCV treatment and co-morbidities such as HIV or substance use.
